Therapeutic Group

Indication Dosage

Empagliflozin and linagliptin are commonly prescribed together as a fixed-dose combination medication for the treatment of type 2 diabetes mellitus. The specific indications and dosage recommendations may vary depending on the country and individual patient factors. It is important to consult a healthcare professional or refer to the prescribing information for precise dosing instructions. However, here is some general information regarding the indications and dosages:

Indications: Empagliflozin and linagliptin combination therapy is indicated for the management of type 2 diabetes mellitus in adults when diet and exercise alone do not provide adequate glycemic control. It is typically used as an adjunct to diet and exercise to improve glycemic control and may be prescribed alongside other antidiabetic medications.

Dosage: The recommended dosage of empagliflozin and linagliptin combination tablets may vary depending on the specific product and the patient's individual needs. It is essential to follow the prescribed instructions provided by the healthcare professional. The tablets are typically taken orally, with or without food, and swallowed whole with water.

Content

Pregnancy

Not recommended

Stability

Contra Indications

Precautions

Lactation

Side Effects